Apply minor pressure on the injection site to prevent any minor bleeding
The alternative is simple
The clinical efficacy is comparable: the OASIS 4 trial showed 13.6% weight loss with the oral 25 mg tablet versus 14.9% for the injection in STEP 1
Sub-diaphragmatic vagus nerve resection did not alter GLP-1-mediated increases in protein kinase A activity in the brain
doi: 10.3389/fphar.2026.1791206 Received 19 January 2026 Revised 13 April 2026 Accepted 14 April 2026 Published 01 May 2026 Volume 17 - 2026 Edited by Kabirullah Lutfy, Western University of Health Sciences, United States Reviewed by Marsida Kallupi, University of California, San Diego, United States Christina Merritt, University of Texas Medical Branch at Galveston, United States Updates Copyright 2026 Hrickova, Demirci, Amchova and Ruda-Kucerova
Eli Lillys Trulicity and Novo Nordisks Ozempic have dominated in recent years, however, while AstraZenecas focus in diabetes shifted to Farxiga, its second best-selling product in 2023